Skip to content

Michael Liu

Case Western Reserve University School of Medicine, Cleveland (Liu, Branning, Lee); Department of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland (Branning, Gao); Departments of Internal Medicine, Pediatrics, and Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland (Kaelber); Center for Clinical Informatics Research and Education, The MetroHealth System, Cleveland (Kaelber); Department of Mind and Body Medicine, Sichuan Lansheng Brain Hospital, Chengdu, China (Gao).

1 paper in the library · 2 citations · publishing 2025

Papers

Racial-Ethnic Disparities in Ketamine and Esketamine Therapy for Major Depressive Disorder.

Psychiatric services (Washington, D.C.) June 25, 2025 Michael Liu, Rachel Branning, Austin Lee et al. 2 citations

Non-Hispanic Black, Hispanic, and Asian patients with moderate-to-severe recurrent major depressive disorder received ketamine at lower rates than non-Hispanic White patients. Esketamine was used less often among Black patients, more often among Hispanic patients, and at similar rates among Asian patients compared with White patients. Black and White patients who received either treatment had more co-occurring medical and psychiatric conditions than those who did not. The findings indicate significant racial-ethnic disparities in access to these advanced therapies, especially for Black patients.